Skip to main content
20 minutes minimum delay
toggle main navigation
Our Approach
Our Approach
NDMA Receptors
Therapeutic Area Focus
Pipeline
Clinical Studies
Investors
About Us
About Aptinyx
Leadership Team
Board of Directors
Working at Aptinyx
Contact Us
Site Search
Press Releases
Investor Relations
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials & Filings
Quarterly Results
Annual Reports & Proxy
SEC Filings
Governance
Governance Documents & Charters
Executive Management
Board of Directors
Committee Composition
FAQ & Contacts
Investor Contacts
Investor FAQs
Investor Email Alerts
RSS Feeds
Normal
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
December 21, 2020
Aptinyx to Present at the 39th Annual J.P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)
December 16, 2020
Aptinyx Appoints Andy Kidd, M.D., President and Chief Operating Officer
Download
PDF format download (opens in new window)
November 12, 2020
Aptinyx Reports Third Quarter 2020 Financial Results and Recent Highlights
Download
PDF format download (opens in new window)
November 10, 2020
Aptinyx to Participate in Upcoming Virtual Investor Conferences
Download
PDF format download (opens in new window)
October 29, 2020
Aptinyx to Report Third Quarter Financial Results on Thursday, November 12, 2020
Download
PDF format download (opens in new window)
October 26, 2020
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Download
PDF format download (opens in new window)
October 21, 2020
Aptinyx Announces Pricing of Public Offering of Common Stock
Download
PDF format download (opens in new window)
October 20, 2020
Aptinyx Announces Proposed Public Offering of Common Stock
Download
PDF format download (opens in new window)
October 19, 2020
Aptinyx Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder
Download
PDF format download (opens in new window)
September 28, 2020
Aptinyx Recommences Patient Recruitment in Phase 2 Study of NYX-2925 in Patients with Fibromyalgia
Download
PDF format download (opens in new window)
September 03, 2020
Aptinyx to Present at Upcoming Virtual Investor Conferences
Download
PDF format download (opens in new window)
August 13, 2020
Aptinyx Reports Second Quarter 2020 Financial Results and Highlights
Download
PDF format download (opens in new window)
August 04, 2020
Aptinyx to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
Download
PDF format download (opens in new window)
July 30, 2020
Aptinyx to Report Second Quarter Financial Results on Thursday, August 13, 2020
Download
PDF format download (opens in new window)
July 08, 2020
Aptinyx to Host PTSD-Focused R&D; Day on August 5th, 2020
Download
PDF format download (opens in new window)
June 26, 2020
Aptinyx to be Added to Russell 2000® Index
Download
PDF format download (opens in new window)
June 18, 2020
Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder
Download
PDF format download (opens in new window)
June 16, 2020
Aptinyx to Present at Upcoming Virtual Investor Conferences
Download
PDF format download (opens in new window)
May 14, 2020
Aptinyx Reports First Quarter 2020 Financial Results and Highlights
Download
PDF format download (opens in new window)
April 30, 2020
Aptinyx to Report First Quarter Financial Results on Thursday, May 14, 2020
Download
PDF format download (opens in new window)
March 30, 2020
Aptinyx Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Download
PDF format download (opens in new window)
March 18, 2020
Aptinyx to Report Fourth Quarter and Full Year 2019 Financial Results on Monday, March 30, 2020
Download
PDF format download (opens in new window)
February 19, 2020
Aptinyx to Present at Upcoming Investor Conferences
Download
PDF format download (opens in new window)
January 30, 2020
Aptinyx Announces Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson’s Disease
Download
PDF format download (opens in new window)
January 14, 2020
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Download
PDF format download (opens in new window)
January 10, 2020
Aptinyx Announces Pricing of Public Offering of Common Stock
Download
PDF format download (opens in new window)
January 09, 2020
Aptinyx Announces Proposed Public Offering of Common Stock
Download
PDF format download (opens in new window)